send to a friend by email
2017-02-19
According to the parent company data of Dar Al-Shifa Pharmaceuticals Company PHARMACARE for the year-end 2016, net profit after tax reached 3,414,672 USD, compared with a net profit after tax of 1,849,164 USD in the audited data for 2015, a net increase of 84.7%. Total assets of the company reached 51,137,343 USD as of December 31st, 2016, compared to total assets of 45,615,682 USD as of December 31st, 2015, a net increase of 12.1%. Total liabilities of the company reached 23,792,491 USD as of December 31st, 2016, compared to total liabilities of 21,072,784 USD as of December 31st, 2015, a net increase of 12.9%. Net ownership equity of the company reached 27,344,853 USD as of December 31st, 2016, compared with a net ownership equity of 24,542,898 USD as of December 31st, 2015, a net increase of 11.4%.
|
|